Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices
In This Article:
Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%. Shares of major U.S. drugmakers Eli Lilly Pfizer Merck AbbVie and Amgen fell between 2.4% and 4.3% in premarket trading Monday. The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.